C-type natriuretic peptide forms in adult hyperthyroidism: Correlation with thyroid hormones and markers of bone turnover

Clinical Endocrinology

Volumn 76, Issue 6, 2012, Pages 790-796

  Schouten, Belinda J ^a   Prickett, Timothy C ^b   Hunt, Penelope J ^a   Richards, A Mark ^b   Geffner, Mitchell E ^c   Olney, Robert C ^d   Espiner, Eric A ^b  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

^d NEMOURS CHILDREN S CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; CARBIMAZOLE; CARBOXY TERMINAL TELOPEPTIDE; CREATININE; LIOTHYRONINE; NATRIURETIC PEPTIDE TYPE C; OSTEOCALCIN; PROCOLLAGEN; PROCOLLAGEN C PROTEINASE; THYROTROPIN;

ADULT; AGED; ARTICLE; BONE TURNOVER; CLINICAL ARTICLE; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; EUTHYROIDISM; FEMALE; HUMAN; HYPERTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; ALKALINE PHOSPHATASE; BONE AND BONES; CARBIMAZOLE; COLLAGEN TYPE I; FEMALE; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, C-TYPE; OSTEOCALCIN; PROSPECTIVE STUDIES; THYROID HORMONES; YOUNG ADULT;

EID: 84860194393     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04295.x     Document Type: Article

References (39)

1. Potter, L.R., Abbey-Hosch, S., &, Dickey, D.M., (2006) Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocrine Reviews, 27, 47-72.
2. Charles, C.J., Prickett, T.C., Espiner, E.A., et al. (2006) Regional sampling and the effects of experimental heart failure in sheep: differential responses in A, B and C-type natriuretic peptides. Peptides, 27, 62-68.
3. Prickett, T.C., Charles, C.J., Yandle, T.G., et al. (2009) Skeletal contributions to plasma CNP forms: evidence from regional sampling in growing lambs. Peptides, 30, 2343-2347.
4. Palmer, S.C., Prickett, T.C., Espiner, E.A., et al. (2009) Regional release and clearance of C-Type natriuretic peptides in the human circulation and relation to cardiac function. Hypertension, 54, 612-618.
5. Chusho, H., Tamura, N., Ogawa, Y., et al. (2001) Dwarfism and early death in mice lacking C-type natriuretic peptide. Proceedings of the National Academy of Sciences of the United States of America, 98, 4016-4021.
6. Olney, R.C., Bukulmez, H., Bartels, C.F., et al. (2006) Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature. Journal of Clinical Endocrinology and Metabolism, 91, 1229-1232.
7. Bartels, C.F., Bukulmez, H., Padayatti, P., et al. (2004) Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. American Journal of Human Genetics, 75, 27-34.
8. Moncla, A., Missirian, C., Cacciagli, P., et al. (2007) A cluster of translocation breakpoints in 2q37 is associated with overexpression of NPPC in patients with a similar overgrowth phenotype. Human Mutation, 28, 1183-1188.
9. Lango Allen, H., Estrada, K., Lettre, G., et al. (2010) Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature, 467, 832-838.
10. Prickett, T.C.R., Lynn, A.M., Barrell, G.K., et al. (2005) Amino-terminal proCNP: a putative marker of cartilage activity in postnatal growth. Pediatric Research, 58, 334-340.
11. Prickett, T.C., Dixon, B., Frampton, C., et al. (2008) Plasma amino-terminal pro C-type natriuretic peptide in the neonate: relation to gestational age and postnatal linear growth. Journal of Clinical Endocrinology and Metabolism, 93, 225-232.
12. Olney, R.C., Prickett, T.C., Yandle, T.G., et al. (2007) Amino-terminal propeptide of C-Type natriuretic peptide and linear growth in children: effects of puberty, testosterone and growth hormone. Journal of Clinical Endocrinology and Metabolism, 92, 4294-4298.
13. Bassett, J.H., &, Williams, G.R., (2003) The molecular actions of thyroid hormone in bone. Trends in Endocrinology & Metabolism, 14, 356-364.
14. Reh, C.S., Olney, R., Azen, C., et al. (2011) Plasma CNP forms and thyroid status in prepubertal children with acquired thyroid disease. Clinical Endocrinology (Oxford), 76, 228-235.
15. Inoue, A., Hiruma, Y., Hirose, S., et al. (1996) Stimulation by C-type natriuretic peptide of the differentiation of clonal osteoblastic MC3T3-E1 cells. Biochemical & Biophysical Research Communications, 221, 703-707.
16. Hagiwara, H., Inoue, A., Yamaguchi, A., et al. (1996) cGMP produced in response to ANP and CNP regulates proliferation and differentiation of osteoblastic cells. American Journal of Physiology-Cell Physiology, 270, C1311-C1318.
17. Schouten, B.J., Prickett, T.C., Hooper, A.A., et al. (2011) Central and peripheral forms of C-type natriuretic peptide (CNP): evidence for differential regulation in plasma and cerebrospinal fluid. Peptides, 32, 797-804.
18. Pantazi, H., &, Papapetrou, P.D., (2000) Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. Journal of Clinical Endocrinology and Metabolism, 85, 1099-1106.
19. Siddiqi, A., Burrin, J.M., Noonan, K., et al. (1997) A longitudinal study of markers of bone turnover in Graves' disease and their value in predicting bone mineral density. Journal of Clinical Endocrinology and Metabolism, 82, 753-759.
20. Garnero, P., Vassy, V., Bertholin, A., et al. (1994) Markers of bone turnover in hyperthyroidism and the effects of treatment. Journal of Clinical Endocrinology and Metabolism, 78, 955-959.
21. MacLeod, J.M., McHardy, K.C., Harvey, R.D., et al. (1993) The early effects of radioiodine therapy for hyperthyroidism on biochemical indices of bone turnover. Clinical Endocrinology (Oxford), 38, 49-53.
22. Holliday, L.S., Dean, A.D., Greenwald, J.E., et al. (1995) C-type natriuretic peptide increases bone resorption in 1,25-dihydroxyvitamin D3-stimulated mouse bone marrow cultures. Journal of Biological Chemistry, 270, 18983-18989.
23. Suda, M., Tanaka, K., Fukushima, M., et al. (1996) C-Type natriuretic peptide as an autocrine/paracrine regulator of osteoblast. Biochemical & Biophysical Research Communications, 223, 1-6.
24. Yasoda, A., Komatsu, Y., Chusho, H., et al. (2004) Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nature Medicine, 10, 80-86.
25. Woods, A., Khan, S., &, Beier, F., (2007) C-Type natriuretic peptide regulates cellular condensation and glycosaminoglycan synthesis during chondrogenesis. Endocrinology, 148, 5030-5041.
26. Inoue, A., Hayakawa, T., Otsuka, E., et al. (1999) Correlation between induction of expression of biglycan and mineralization by C-type natriuretic peptide in osteoblastic cells. Journal of Biochemistry, 125, 103-108.
27. Heymann, D., &, Rousselle, A.V., (2000) gp130 cytokine family and bone cells. Cytokine, 12, 1455-1468.
28. Broderick, K.E., Zhang, T., Rangaswami, H., et al. (2007) Guanosine 3',5'-Cyclic monophosphate (cGMP)/cGMP-dependent protein kinase Induce interleukin-6 transcription in osteoblasts. Molecular Endocrinology, 21, 1148-1162.
29. Seibel, M.J., (2005) Biochemical markers of bone turnover: part I: biochemistry and variability. Clinical Biochemist Reviews, 26, 97-122.
30. Sims, N.A., &, Gooi, J.H., (2008) Bone remodeling: multiple cellular interactions required for coupling of bone formation and resorption. Seminars in Cell and Developmental Biology, 19, 444-451.
31. Bocciardi, R., Giorda, R., Buttgereit, J., et al. (2007) Overexpression of the C-type natriuretic peptide (CNP) is associated with overgrowth and bone anomalies in an individual with balanced t(2;7) translocation. Human Mutation, 28, 724-731.
32. Kohno, M., Murakawa, K., Yasunari, K., et al. (1987) Circulating atrial natriuretic peptides in hyperthyroidism and hypothyroidism. American Journal of Medicine, 83, 648-652.
33. Kohno, M., Horio, T., Yasunari, K., et al. (1993) Stimulation of brain natriuretic peptide release from the heart by thyroid hormone. Metabolism, 42, 1059-1064.
34. Ladenson, P.W., Bloch, K.D., &, Seidman, J.G., (1988) Modulation of atrial natriuretic factor by thyroid hormone: messenger ribonucleic acid and peptide levels in hypothyroid, euthyroid, and hyperthyroid rat atria and ventricles. Endocrinology, 123, 652-657.
35. Dai, G., Kaazempur-Mofrad, M.R., Natarajan, S., et al. (2004) Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature. Proceedings of the National Academy of Sciences of the United States of America, 101, 14871-14876.
36. Parmar, K.M., Larman, H.B., Dai, G., et al. (2006) Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. Journal of Clinical Investigation, 116, 49-58.
37. Kake, T., Kitamura, H., Adachi, Y., et al. (2009) Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice. American Journal of Physiology-Endocrinology and Metabolism, 297, E1339-E1348.
38. Hunt, P.J., Richards, A.M., Espiner, E.A., et al. (1994) Bioactivity and metabolism of C-type natriuretic peptide in normal man. Journal of Clinical Endocrinology & Metabolism, 78, 1428-1435.
39. Prickett, T.C.R., Bothwell, J.C., Yandle, T.G., Richards, A.M., &, Espiner, E.A., (2012) Pharmacodynamic responses of plasma and tissue C-Type Natriuretic Peptide (CNP) to GH: correlation with linear growth in GH deficient rats. Journal of Endocrinology, 212, 1-10.